Antineutrophil cytoplasmic antibody-associated vasculitis: Experience from Taichung Veterans General Hospital 施凱翔 梁凱莉 顏廷廷.

Slides:



Advertisements
Similar presentations
Vasculitis Philip Seo, MD, MHS Co-Director, the Johns Hopkins Vasculitis Center Compassionate Allowances Outreach Hearing on Autoimmune Diseases 16 March.
Advertisements

ABSTRACT ID - IRIA-1230 Imaging differentials in granulomatous diseases of head and neck: a retrospective study.
Grand Rounds Eddie Apenbrinck M.D. University of Louisville School of Medicine Department of Ophthalmology & Visual Sciences 3/7/2014.
Vasculitis CVS 7 Hisham Alkhalidi.
Wegener’s Granulomatosis
1 Clinical Presentation of GPA Jessica Meikle E2-CBL 10/13/2011.
Jason Kidd Morning Report 11/18/2009 Wegener: Controversy “Unlike doctors who joined the Nazi Party to be allowed to practice, Wegener joined the movement.
Resident Report Wegener’s Granulomatosis Small vessel vasculitis Typical areas affected are sinus, upper airway, lungs, kidney Progressive course.
Morning Report January 19 th, 2010 Jason Kidd.
ANCA disease: immunoserology and pathogenesis Alenka Vizjak Institute of Pathology · Faculty of Medicine University of Ljubljana, Ljubljana, Slovenia.
Wegener’s Granulomatosis Kristine Scruggs AM Report 14 September 2009.
Vasculitides (Vasculitis) Dr. Raid Jastania. Vasculitis Inflammation of the walls of the vessels Causes of inflammation: –Infectious, physical, chemical,
ANCA disease: immunoserology and pathogenesis
Blood Vessels. Pathology Congenital Anomalies Arteriosclerosis HTN Vasculitides ( inflammations) Aneurysms & Dissections Veins & Lymphatics Tumors.
Vasculitis Hisham Alkhalidi.
Nasal Granulomas. A granuloma is a tumour like mass of nodular granulation tissue with actively growing fibrobasts and capillary buds due to chronic inflammatory.
WEGENER’S GRANULOMATOSIS
WEGENERS GRANULOMATOSIS By: Camille Baker & Allie Clark.
Churg-Strauss Syndrome: Dispelling the Myths
Vasculitis Sufia Husain Pathology Department KSU, Riyadh March 2014.
WEGENER’S GRANULOMATOSIS L.Grcevska Department of Nephrology Faculty of Medicine Skopje, R.Macedonia.
Nephrology Diseases & Chemotherapy. Idiopathic Nephrotic Syndrome (NS) Caused by renal diseases that increase the permeability across the glomerular filtration.
Vasculitis Vasculitis arises when immune system mistakenly attacks blood vessels. What causes this attack isn't fully known, but it can result from infection.
Diagnostic Approach to Vasculitis
Radiology 08/12/ /25/2009.
E Ure, Y Kayadibi, D Tekcan Sanli, Z I Hasiloglu
A woman with multiple mononeuropathies and eosinophilia Teaching NeuroImages Neurology Resident and Fellow Section © 2014 American Academy of Neurology.
Vasculitis Shaesta Naseem.
Causes and Treatment of Wegener’s granulomatosis Alicia Yu Yifan (Emily) Hu Grace Tang Jessica Wu PHM142 October 20, 2015 PHM142 Fall 2015 Coordinator:
Systemic Vasculitis: a clinical approach
Clinical/Laboratory features and Diagnosis of Wegener’s G. Iraj Salehi-Abari, MD. Iraj Salehi-Abari Wegener G.
Vasculitis Inflammation of the vessel wall. Signs and symptoms:
Vasculitis Hisham Alkhalidi. Vasculitis Vascular inflammatory injury, often with necrosis.
Goodpasture’s Syndrome and Anti- GBM disease. Goodpasture’s Syndrome Introduction Concurrence of pulmonary hemorrhage and focal necrotizing glomerulonephritis.
The Pulmonary Vasculitides
Granulomatosis with polyangiitis (GPA) is a systemic vasculitis that usually involves the lungs, upper respiratory tract and kidneys. Common presentations.
Vasculitis CVS 7 Hisham Alkhalidi.
Actinomycosis.
CASE Review. Current Problems Underlying Graves’ disease Administration of propylthiouracil Pancytopenia Hemoptysis Serology : ANA (+) Anti- Ro, Anti-
SQUAMOUS CELL CARCINOMA OF MIDDLE EAR A CASE REPORT DR.ALEENA REHMAN(JR 1) DR.SUSHIL GAUR(AP) DR.O N SINHA (HOD) SANTOSH MEDICAL COLLEGE.
Microscopic Polyangiitis and Pauci-immune Glomerulonephritis
19th INTERNATIONAL SYMPOSIUM ON RECENT ADVANCES IN OTITIS MEDIA
1st case Dr Nedi Zannettou hadjichristofi Physician rheumatologist
Site(s) of Involvement Serum IgG4 Level (mg/dL) Treatment with Steroid
Vasculitis Inflammation of the vessel wall. Signs and symptoms:
Miliary TB.
CLINICAL PROFILE OF DENGUE FEVER
Recurrence of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis in Appropriately Immunosuppressed Renal Transplant Patients: A Discussion of Two.
ANCA associated vasculitides
Copyright © 2003 American Medical Association. All rights reserved.
Assistant professor of pathology
Relationship between CMV & PU disease
Vasculitis Pathology Department KSU, Riyadh 2015.
From: Antiproteinase 3 Antineutrophil Cytoplasmic Antibodies and Disease Activity in Wegener Granulomatosis Ann Intern Med. 2007;147(9): doi: /
Part 9A: Wegener’s Granulomatosis
N.Movaffagh MD Rheumatologist
Dr Rachael Kilding Consultant Rheumatologist 29th February 2016
Nat. Rev. Rheumatol. doi: /nrrheum
Vasculitis Sufia Husain Pathology Department KSU, Riyadh March 2018
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis)
Nat. Rev. Rheumatol. doi: /nrrheum
National Cancer Statistics in Korea, 2015
Nat. Rev. Rheumatol. doi: /nrrheum
2016 합동집담회 증례 발표 서울대학교병원 영상의학과 유진영.
DIFFUSE ALVEOLAR HEMORRHAGE SYNDROM
Kaplan–Meier curves for the time until development of microscopic polyangiitis (MPA) in patients with idiopathic pulmonary fibrosis according to antineutrophil.
Charcot-Leyden crystal concentration in nasal secretions predicts clinical response to glucocorticoids in patients with chronic rhinosinusitis with nasal.
Frequency of PR3-ANCA and MPO-ANCA positivity in ANCA-positive patients with a particular organ system involvement in an inception cohort of 502 ANCA vasculitis.
ANCA-Associated Vasculitis: Core Curriculum 2020
Presentation transcript:

Antineutrophil cytoplasmic antibody-associated vasculitis: Experience from Taichung Veterans General Hospital 施凱翔 梁凱莉 顏廷廷

ANCA-associated vasculitis: 3 kinds of small vessel disease Microscopic Polyangiitis Granulomatosis with Polyangiitis (Wegener’s granulomatosis) Eosinophilic Granulomatous with polypangitis (Churg-Strauss syndrome) MPA GPA EGPA

Anti-neutrophil cytoplasmic antibody (ANCA): ANCA activates neutrophils with subsequent activation of the complement pathway, results in vascular damage, non-resolving chronic inflammation Two kinds of staining pattern of ANCA: P-ANCA (staining of MPO) and C-ANCA (staining of PR3) MPO: myeloperoxidase  PR3: proteinase 3

Clinical manifestations: localized or generalized

Patients and Methods Retrospective chart review of patients with ANCA-associated vasculitis based on the classification criteria of American College of Rheumatology and definitions described at the Chapel Hill Consensus Conference 2012

Results From March 2004 to March 2017: 11 patients with ANCA-associated vasculitis were enrolled (9 GPA, 1 MPA, and 1 EGPA) Characteristics Patient (N = 11) N (%) Sex Female Male 8 (73) 3 (27) Age of Dx -yr median (range) distribution -N (%) 18-40 yrs 40-64 yrs ≥65 yrs 44 (20-73) 5 (45) 1 (9)

Results Clinical manifestations Patients (N=11) N (%) Rhinosinusitis Rhinitis or nasal symptoms Sinusitis 11 (100) 10 (91) 7 (64) Fever Hearing impairment 4 (36) Ocular involvement 5 (45) Lung involvement Trachea involvement 6 (55) 2 (18) Renal involvement Central nervous system involvement Mucocutaneous involvement Gastrointestinal involvement 1 (9)

Nose and Sinus: Most common manifestation Usually present with nasal obstruction, rhinorrhea, or bloody nasal discharge

Nose and Sinus: Tissue damage and bone destruction caused by vasculitis Chronic inflammation could result in anosmia, septal perforation, and saddle nose

Ear and peripheral facial palsy Sensorineural hearing loss Otitis media/ effusion/ mastoiditis Facial palsy

Larynx and Trachea, orbit Glotic ulcer or subglottic stenosis Orbital pseudotumor Episcleritis, scleritis

Salivary glands and mucocutaneous findings Parotid or submandibular glands may be swollen and sore

Surrogate markers Serology testing Patients (N = 11) N (%) ANCA positive PR3-ANCA MPO-ANCA 11(100) 6(55) 5(45) GPA n=9 6(67) 3(33) ANA positive ANA equivocal 1(9) 3(27)

Pathological features Nine out of 11 patients had pathological diagnoses. Multiple biopsies in few patients Most positive pathology came from sinonasal regions. Necrotizing granuloma Vasculitis

Treatment modality and outcomes Steroid (11, 100%), cyclophosphamide (7, 63%) Rituximab (6, 45%) Ten out of 11 patients were alive at the end of this study One patient with GPA died from septic shock The disease relapse in 4 out of 9 GPA patients and need additional therapy

Discussions The annual incidence of GPA in Taiwan was 0.37 per million patient-years from 1997 to 2008, according to the NHI database The annual incidence of GPA in Europe was about 4.9 to 10.6 per million years according to different regions Journal of Microbiology, Immunology and Infection, 2015, 48.5: 477-482. Ann Rheum Dis. 2001 Dec; 60(12): 1156–1157.

Discussions Five out of our patients initially seek medical help to ENT doctors. Most patients had multi-system involvement except one. Time between the first show-up to diagnosis range from 1 to 11 months

Discussions GPA MPA EPGA Our study Treatment outcome of our patients was not inferior to literature review GPA MPA EPGA Our study Remission rate 30-93% 75-89% 81-91% 100% 5-year survival 74-91% 45-76% 60-97% 91% Relapse (variably defined) 18-60% 8% 35% 44% Annals of the rheumatic diseases 67.7 (2008): 1004-1010.

Conclusions Otorhinolaryngologist could be the first physician to contact the patients with ANCA-associated vasculitis. This diagnosis must always be taken into consideration in patient with atypical symptoms or unresponsive to standard treatment.

Conclusions Harvest multiple sites, adequate tissue biopsy helps to make diagnosis. Early diagnosis is crucial for therapy implementation and allows avoid irreversible organ damage.

Thank you!